Banner

Point Of Care Molecular Diagnostics Global Market Report 2023 – By Product And Service (Assays And Kits, Instruments And Analyzers, Software And Services), By Technology (Reverse Transcription Polymerase Chain Reaction, In Situ Hybridization, Sequencing), By Application, Respiratory Diseases, Hospital Acquired Infections, Cancer, Hepatitis, Hematology), By End-User (Decentralized Labs, Hospitals, Home Care, Assisted Living Healthcare Facilities) – Market Size, Trends, And Global Forecast 2023-2032 

Starting Price : $5000.00 | Pages : 200 | Published : January 2023 | SKU CODE : h2489 | Delivery Time: 2-3 business days | Format :


Point-of-care (POC) molecular diagnostics refers to tests that detect the presence of specific nucleic acids in a clinical specimen, such as feces, saliva, urine, blood, and tissue. This molecular diagnostic is based on seeing targeted portions of microbial genetic material, DNA or RNA. It is utilized by the healthcare sector to detect emergency usage authorization to diagnose diseases. Point-of-care (POC) molecular diagnostic is used to detection of disease antigens or antibodies in human samples, such as mononucleosis, influenza, and group A streptococcus (GAS). 

The main product and services of point-of-care molecular diagnostics are assays and kits, instruments and analyzers and software and services. Assays and kits refer to the equipment which is used in carrying out analyses such as studying disease pathways. Assays and kits were widely used for detecting rapid and accurate diagnosing and monitoring various diseases. Reverse transcription-polymerase chain reaction (RT-PCR), in situ-hybridization and sequencing are the technologies used in point-of-care molecular diagnostics that are used for diagnosis of diseases such as respiratory diseases, hospital-acquired infections (HAIs), cancer/oncology, hepatitis and hematology. Decentralized labs, hospitals, home care, and assisted living healthcare facilities use point of care molecular diagnostics.

The point-of-care molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides point-of-care molecular diagnostics market statistics, including point-of-care molecular diagnostics industry global market size, regional shares, competitors with a point-of-care molecular diagnostics market share, detailed point-of-care molecular diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care molecular diagnostics industry. This point-of-care molecular diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The global point-of-care molecular diagnostics market size grew from $2.8 billion in 2022 to $3.14 billion in 2023 at a compound annual growth rate (CAGR) of 12.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The point-of-care molecular diagnostics market size is expected to grow to $4.98 billion in 2027 at a CAGR of 12.2%.

The rapid growth in the increasing occurrence of infectious and respiratory diseases is expected to significantly contribute to the growth of the point-of-care molecular diagnostics market. Respiratory infections, such as viruses or bacteria, are caused by microorganisms that influence the respiratory system. These microbes can be transferred through coughing, sneezing, or direct touch. The severity of the respiratory medications includes a variety of inhalers, oral medications, intravenous treatments, and point-of-care molecular diagnostic to cure the patient. For instance, in May 2020, an annual Report on MCCD (Medical Certification of Cause of Death) 2020 shows that respiratory system diseases are the second most common cause of death, accounting for 10% of the total medically certified causes of death (88.7%). Furthermore, between 2019 and 2020, the number of deaths caused by respiratory disorders increased from 152,311 to 181,160. Therefore, the rapid occurrence of infectious and respiratory diseases and death will drive the point-of-care-molecular diagnostics market.

Technological innovation is a key trend gaining popularity in the point-of-care molecular diagnostics market. Major companies operating in the point-of-care molecular diagnostics market are focused on providing technologically advanced solutions to strengthen their market position. These companies are implementing next-generation point-of-care molecular diagnostics technologies solutions and related services, such as enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), and mass spectrometry (MS), situ hybridizations, spectral karyotyping imaging, DNA microarrays, and others to implement on POC devices with features of accelerating analysis times and lowering costs. For instance, in March 2020, Abbott Laboratories, a US-based medical device company, launched the molecular point-of-care test available for detecting new COVID-19 (COVID-19). According to the company, the device shows positive results in five minutes and negative in 13 minutes. This test will run on the ID NOW™ platform with isothermal nucleic acid amplification technology that generates molecular results in minutes.

In February 2021, Thermo Fisher Scientific, a US-based supplier of scientific instrumentation, reagents, consumables, and software services firm acquired Mesa Biotech for an undisclosed amount. With this acquisition, Thermo Fisher Scientific will expand into molecular diagnostics at the point-of-care by bringing much-needed diagnostics to market on a larger scale. Mesa Biotech is a US-based point-of-care molecular diagnostic company.

Major players in the point-of-care molecular diagnostics market are Abbott Laboratories, F Hoffmann-La Roche Ltd., BioMérieux SA, Danaher Corporation, Quidel Corporation, Qiagen Gmbh, Biocartis NV, Nova Biomedical, Thermo Fisher Scientific, Dickinson and Company, Mesa Biotech Inc., OraSure Technologies Inc., Bio-Rad Laboratories Inc., Sysmex, Siemens Healthineers, Bayer HealthCare Pharmaceuticals LLC, Alere Inc., Lucira Health Inc., Cue Health, OpGen Inc., Binx Health Inc., Molbio Diagnostics Pct Ltd., Genomadix, Visby Medical, QuikPath PTE Ltd., QuantuMDx Group Ltd and Sekisui Medical Co Ltd.

North America was the largest region in the point-of-care molecular diagnostics market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the point-of-care molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The point-of-care (POC) molecular diagnostics market includes revenues earned by AAT, antigen, or antibody tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. 

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The global point of care molecular diagnostics market is segmented -

1) By Product And Service: Assays And Kits, Instruments And Analyzers, Software And Services

2) By Technology: Reverse Transcription - Polymerase Chain Reaction (RT-PCR), In Situ Hybridization, Sequencing

3) By Application: Respiratory Diseases, Hospital Acquired Infections (HAIs), Cancer/Oncology, Hepatitis, Hematology

4) By End-User: Decentralized Labs, Hospitals, Home Care, Assisted Living Healthcare Facilities

    Table Of Contents

    1. Executive Summary

    2. Point-Of-Care Molecular Diagnostics Market Characteristics

    3. Point-Of-Care Molecular Diagnostics Market Trends And Strategies

    4. Point-Of-Care Molecular Diagnostics – Macro Economic Scenario

    4.1 COVID-19 Impact On Point-Of-Care Molecular Diagnostics Market

    4.2 Ukraine-Russia War Impact On Point-Of-Care Molecular Diagnostics Market

    4.3 Impact Of High Inflation On Point-Of-Care Molecular Diagnostics Market

    5. Point-Of-Care Molecular Diagnostics Market Size And Growth

    5.1. Global Point-Of-Care Molecular Diagnostics Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Point-Of-Care Molecular Diagnostics Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Point-Of-Care Molecular Diagnostics Market Segmentation

    6.1. Global Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Assays And Kits

    Instruments And Analyzers

    Software And Services

    6.2. Global Point-Of-Care Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Reverse Transcription - Polymerase Chain Reaction (RT-PCR)

    In Situ Hybridization

    Sequencing

    6.3. Global Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Respiratory Diseases

    Hospital Acquired Infections (HAIs)

    Cancer/Oncology

    Hepatitis

    Hematology

    6.4. Global Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Decentralized Labs

    Hospitals

    Home Care

    Assisted Living Healthcare Facilities

    7. Point-Of-Care Molecular Diagnostics Market Regional And Country Analysis

    7.1. Global Point-Of-Care Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Point-Of-Care Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Point-Of-Care Molecular Diagnostics Market  

    8.1. Asia-Pacific Point-Of-Care Molecular Diagnostics Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Point-Of-Care Molecular Diagnostics Market  

    9.1. China Point-Of-Care Molecular Diagnostics Market Overview  

    9.2. China Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Point-Of-Care Molecular Diagnostics Market  

    10.1. India Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Point-Of-Care Molecular Diagnostics Market  

    11.1. Japan Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Point-Of-Care Molecular Diagnostics Market  

    12.1. Australia Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Point-Of-Care Molecular Diagnostics Market  

    13.1. Indonesia Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Point-Of-Care Molecular Diagnostics Market  

    14.1. South Korea Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Point-Of-Care Molecular Diagnostics Market  

    15.1. Western Europe Point-Of-Care Molecular Diagnostics Market Overview

    15.2. Western Europe Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Point-Of-Care Molecular Diagnostics Market  

    16.1. UK Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Point-Of-Care Molecular Diagnostics Market  

    17.1. Germany Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Point-Of-Care Molecular Diagnostics Market  

    18.4. France Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Point-Of-Care Molecular Diagnostics Market  

    19.1. Eastern Europe Point-Of-Care Molecular Diagnostics Market Overview

    19.2. Eastern Europe Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Point-Of-Care Molecular Diagnostics Market  

    20.1. Russia Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Point-Of-Care Molecular Diagnostics Market  

    21.1. North America Point-Of-Care Molecular Diagnostics Market Overview

    21.2. North America Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Point-Of-Care Molecular Diagnostics Market  

    22.1. USA Point-Of-Care Molecular Diagnostics Market Overview

    22.2. USA Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Point-Of-Care Molecular Diagnostics Market  

    23.1. South America Point-Of-Care Molecular Diagnostics Market Overview

    23.2. South America Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Point-Of-Care Molecular Diagnostics Market  

    24.1. Brazil Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Point-Of-Care Molecular Diagnostics Market  

    25.1. Middle East Point-Of-Care Molecular Diagnostics Market Overview

    25.2. Middle East Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Point-Of-Care Molecular Diagnostics Market  

    26.1. Africa Point-Of-Care Molecular Diagnostics Market Overview

    26.2. Africa Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Point-Of-Care Molecular Diagnostics Market Competitive Landscape And Company Profiles

    27.1. Point-Of-Care Molecular Diagnostics Market Competitive Landscape

    27.2. Point-Of-Care Molecular Diagnostics Market Company Profiles

    27.2.1. Abbott Laboratories  

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. F Hoffmann-La Roche Ltd

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. BioMérieux SA 

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Danaher Corporation

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Quidel Corporation

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Point-Of-Care Molecular Diagnostics Market

    29. Point-Of-Care Molecular Diagnostics Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Point-Of-Care Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Point-Of-Care Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Global Point-Of-Care Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: Asia-Pacific, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: China, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: India, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: India, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Japan, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Japan, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Australia, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Australia, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Indonesia, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: Indonesia, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: South Korea, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: South Korea, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Western Europe, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: Western Europe, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: UK, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: UK, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Germany, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: Germany, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: France, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: France, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Eastern Europe, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Eastern Europe, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Russia, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: Russia, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: North America, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: North America, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: USA, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: USA, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: South America, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: South America, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Brazil, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Brazil, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Middle East, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Middle East, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Africa, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: Africa, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 47: Abbott Laboratories  Financial Performance
  • Table 48: F Hoffmann-La Roche Ltd Financial Performance
  • Table 49: BioMérieux SA  Financial Performance
  • Table 50: Danaher Corporation Financial Performance
  • Table 51: Quidel Corporation Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Point-Of-Care Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Point-Of-Care Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Global Point-Of-Care Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: Asia-Pacific, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: China, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: India, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: India, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Japan, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Japan, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Australia, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Australia, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Indonesia, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: Indonesia, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: South Korea, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: South Korea, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Western Europe, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: Western Europe, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: UK, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: UK, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Germany, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: Germany, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: France, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: France, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Eastern Europe, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Eastern Europe, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Russia, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: Russia, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: North America, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: North America, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: USA, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: USA, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: South America, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: South America, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Brazil, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Brazil, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Middle East, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Middle East, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Africa, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: Africa, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 47: Abbott Laboratories  Financial Performance
  • Figure 48: F Hoffmann-La Roche Ltd Financial Performance
  • Figure 49: BioMérieux SA  Financial Performance
  • Figure 50: Danaher Corporation Financial Performance
  • Figure 51: Quidel Corporation Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report